ADE

See the following -

DSS, Inc. and Hospira Complete the Department of Veterans Affairs’ Innovation Initiative Adverse Drug Events Pilot Program to Further Enhance Veteran Care

Press Release | DSS, Inc., Hospira's TheraDoc Clinical Surveillance System, Hospira | July 18, 2012

DSS, Inc., the leading provider of software development and support for VistA and vxVistA, in partnership with Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced the completion of the Department of Veterans Affairs’ (VA) Innovation Initiative Adverse Drug Events (ADE) project. Read More »